Merck has been found negligent in Texas in the first Vioxx decision, with a $253 million award of which $229 million is punitive based on the jury’s calculation about the expected cost savings Merck incurred by putting off labeling changes. If you shorted Merck stock as your physician’s hedge fund had suggested you are going to start making money soon: Merck is down 8% at the close on Friday.